- Home
- PUBM vs HUMA Comparison
PUBM vs HUMA Comparison
Compare PUBM & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PUBM
- HUMA
- Stock Information
- Founded
- PUBM 2006
- HUMA 2004
- Country
- PUBM United States
- HUMA United States
- Employees
- PUBM N/A
- HUMA N/A
- Industry
- PUBM Computer Software: Prepackaged Software
- HUMA Biotechnology: Pharmaceutical Preparations
- Sector
- PUBM Technology
- HUMA Health Care
- Exchange
- PUBM Nasdaq
- HUMA Nasdaq
- Market Cap
- PUBM 515.8M
- HUMA 427.2M
- IPO Year
- PUBM 2020
- HUMA N/A
- Fundamental
- Price
- PUBM $9.14
- HUMA $1.71
- Analyst Decision
- PUBM Buy
- HUMA Strong Buy
- Analyst Count
- PUBM 11
- HUMA 6
- Target Price
- PUBM $23.30
- HUMA $14.60
- AVG Volume (30 Days)
- PUBM 638.2K
- HUMA 4.0M
- Earning Date
- PUBM 05-06-2025
- HUMA 03-28-2025
- Dividend Yield
- PUBM N/A
- HUMA N/A
- EPS Growth
- PUBM 43.75
- HUMA N/A
- EPS
- PUBM 0.23
- HUMA N/A
- Revenue
- PUBM $291,256,000.00
- HUMA N/A
- Revenue This Year
- PUBM $4.07
- HUMA N/A
- Revenue Next Year
- PUBM $10.05
- HUMA $1,217.58
- P/E Ratio
- PUBM $39.72
- HUMA N/A
- Revenue Growth
- PUBM 9.08
- HUMA N/A
- 52 Week Low
- PUBM $8.90
- HUMA $1.70
- 52 Week High
- PUBM $25.36
- HUMA $9.97
- Technical
- Relative Strength Index (RSI)
- PUBM 30.67
- HUMA 24.32
- Support Level
- PUBM $9.40
- HUMA $1.96
- Resistance Level
- PUBM $10.59
- HUMA $3.36
- Average True Range (ATR)
- PUBM 0.43
- HUMA 0.24
- MACD
- PUBM 0.16
- HUMA -0.11
- Stochastic Oscillator
- PUBM 14.22
- HUMA 0.30
About PUBM PubMatic Inc.
PubMatic is one of the leading supply-side platform providers in the digital advertising technology market. These platforms help publishers, which supply digital ad inventory, better manage their inventory, selling a high percentage of their inventory (increase the ad fill rate) and maximizing revenue per ad sold (optimize yield). PubMatic generates revenue mainly via taking a piece of the ad sales that it enables. Buyers on the platform include intermediary buyers, such as demand-side platforms, or advertisers and ad agencies directly. Given the growth in overall digital advertising, more publishers and advertisers are adopting programmatic (or automated) buying and selling, driving the firm's success in attracting more inventory.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.